The Beauty Health Company (NASDAQ:SKIN) Q4 2022 Earnings Call Transcript

Page 7 of 7

Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Andrew Stanleick for closing remarks.

Andrew Stanleick: Well, thank you, everyone, for your questions. Just to close, I’ll reiterate our confidence in the path forward. I think with our investments now already complete, we have the infrastructure in place to deliver on our profitable growth strategy. I think we have an exciting year ahead with Syndeo’s Q2 international launch, differentiated partnerships to drive consumable sales and recruit new consumers to the brand, China’s reopening and the integration of SkinStylus. So we look forward to continue to execute and further our category leadership in 2023 and beyond. The team will be available today for any additional questions you have. Once again, thank you, and have a great day ahead.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Beauty Health Co

Page 7 of 7